Trial
NCT04138875
A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
PTLD
Intervention
Rituximab
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-23